Treatment Patterns, Healthcare Resource Utilization, and Costs Among Medicare Patients with Multiple Sclerosis in Relation to Disease-Modifying Therapy and Corticosteroid Treatment

被引:0
作者
Marie Sanchirico
Amanda Caldwell-Tarr
Pallavi Mudumby
Lobat Hashemi
Robert Dufour
机构
[1] Sanofi,
[2] Comprehensive Health Insights,undefined
[3] A Humana Company,undefined
来源
Neurology and Therapy | 2019年 / 8卷
关键词
Corticosteroid treatment; Disease-modifying therapy; Healthcare resource utilization; Healthcare costs; Medicare; Multiple sclerosis; Relapse;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:121 / 133
页数:12
相关论文
共 93 条
[21]  
Tremlett H(2017)Impact of multiple sclerosis on patients’ daily activities, emotional well-being and relationships: results of the global vsMS™ survey Neurology. 88 P3.334-undefined
[22]  
Leung S(2014)Change in perceived health insurance coverage among people with multiple sclerosis Int J MS Care. 16 132-undefined
[23]  
Marrie R(2013)Facilitating medication adherence in patients with multiple sclerosis Int J MS Care. 15 36-undefined
[24]  
Horwitz R(2011)Comparison of adherence and persistence among multiple sclerosis patients treated with disease-modifying therapies: a retrospective administrative claims analysis Patient Prefer Adherence. 5 73-undefined
[25]  
Cutter G(2017)Immunosenescence: the role of aging in the predisposition to neuro-infectious complications arising from the treatment of multiple sclerosis Curr Neurol Neurosci Rep. 17 61-undefined
[26]  
Tyry T(2013)An update on new and emerging therapies for relapsing-remitting multiple sclerosis Am J Manag Care. 19 s343-undefined
[27]  
Campagnolo D(undefined)undefined undefined undefined undefined-undefined
[28]  
Vollmer T(undefined)undefined undefined undefined undefined-undefined
[29]  
Margolis JM(undefined)undefined undefined undefined undefined-undefined
[30]  
Fowler R(undefined)undefined undefined undefined undefined-undefined